Skip to content
VynCo is in public beta — we'd love your feedback.

TOLREMO therapeutics Ltd

CHE-350.476.582·Basel, BS

Aktiengesellschaft

Active

Capital

CHF 2'424'359

CHF

Founded

2017

21 Mar 2017

Data Quality

Enriched

Sparql

Purpose

Der Zweck der Gesellschaft ist die Forschung, die Entwicklung und der Vertrieb von Krebsmedikamenten. Die Gesellschaft kann sich daneben an anderen Unternehmen irgendwelcher Art im In- und Ausland bet

Want deeper insights?

See board members, auditor history, and risk analysis.

Start Free
Get notified when this company changes

Create a free account to set up change alerts

Company Details

Legal Form
Aktiengesellschaft
Address
Hochbergerstrasse 60C, Basel
Municipality
Basel
Canton
BS
Data Source
Sparql
Last Modified
8 Jun 2026

Sign up to see board members, auditor history, and recent registry changes for this company.

View full intelligence

More companies in BS

Explore other companies registered in BS

Browse all companies in BS

Basel-Stadt (BS)

Get Full Intelligence

Sign up free for complete company data: board members, auditor history, registry change tracking, and entity screening. AI risk scoring is included with the Professional tier.

TOLREMO therapeutics Ltd — BS | VynCo | VynCo